首页 > 最新文献

Cardiology in the Young最新文献

英文 中文
Global left ventricular relaxation index in predicting cardiac cellular rejection in paediatric heart transplant patients. 预测小儿心脏移植患者心脏细胞排斥反应的整体左心室松弛指数。
IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-07 DOI: 10.1017/S1047951124035959
Kishore R Raja, Amr El Bokl, Farida Karim, Nathan Rodgers, Varun Aggarwal, Benjamin W Langworthy, Jack M Wolf, Daniel Peck

Background: Endomyocardial biopsy remains the gold standard for cardiac cellular rejection surveillance after heart transplantation. We studied a novel non-invasive index of left ventricular relaxation to detect cardiac cellular rejection in paediatric heart transplant patients.

Methods: This is a single-centre retrospective study of paediatric heart transplant patients who underwent endomyocardial biopsy from June 2014 to September 2021. Left ventricular relaxation index was calculated as the sum of diastolic tissue Doppler imaging velocities (E) of the left ventricular lateral, septal, and posterior walls divided by the percentage of the left ventricular posterior wall thinning by M-mode. Statistical analysis included t-tests and Mann-Whitney tests to compare means and medians between treatment and non-treatment groups. We used the cut-off with the maximum Youden index to compare the sensitivity and specificity of left ventricular relaxation index to detect rejection.

Results: The study included 65 patients who underwent 246 cardiac catheterizations and endomyocardial biopsies. Out of 246, 192 procedures were included and 54 were excluded due to recent transplants or lack of echocardiographic data. A total of 114 demonstrated Grade 0R, 68 Grade 1R, 8 Grade 2R, and 2 Grade 3R allograft rejection. The difference in mean left ventricular relaxation index between treatment versus non-treatment groups (2R, 3R vs. 0R, 1R) was not statistically significant (p = 0.917). A left ventricular relaxation index cut-off of 0.73 had the highest Youden index with good sensitivity (100%) and poor specificity (23%) for detecting rejections with grades 2R and 3R.

Conclusion: Left ventricular relaxation index, a novel index of left ventricular relaxation, was not a sensitive or specific predictor of cardiac cellular rejection in paediatric heart transplants.

背景:心内膜活检仍是心脏移植术后监测心脏细胞排斥反应的金标准。我们研究了一种新型无创左心室松弛指数,用于检测儿科心脏移植患者的心脏细胞排斥反应:这是一项单中心回顾性研究,研究对象为2014年6月至2021年9月期间接受心内膜心肌活检的儿科心脏移植患者。左心室松弛指数的计算方法是左心室侧壁、室间隔和后壁舒张期组织多普勒成像速度(E)之和除以M模式下左心室后壁变薄的百分比。统计分析包括 t 检验和 Mann-Whitney 检验,以比较治疗组和非治疗组的平均值和中位数。我们以最大尤登指数为临界值,比较左心室舒张指数检测排斥反应的敏感性和特异性:研究共纳入了 65 名患者,他们接受了 246 次心导管检查和心内膜活检。在 246 例患者中,192 例被纳入,54 例因近期移植或缺乏超声心动图数据而被排除。共有114例显示出0级排斥反应,68例显示出1级排斥反应,8例显示出2级排斥反应,2例显示出3级排斥反应。治疗组与非治疗组(2R、3R 与 0R、1R)的平均左心室松弛指数差异无统计学意义(P = 0.917)。左心室松弛指数临界值为 0.73 时,Youden 指数最高,检测 2R 和 3R 级排斥反应的灵敏度高(100%),特异性低(23%):结论:左心室松弛指数是一种新的左心室松弛指数,它不是预测小儿心脏移植中心脏细胞排斥反应的敏感或特异指标。
{"title":"Global left ventricular relaxation index in predicting cardiac cellular rejection in paediatric heart transplant patients.","authors":"Kishore R Raja, Amr El Bokl, Farida Karim, Nathan Rodgers, Varun Aggarwal, Benjamin W Langworthy, Jack M Wolf, Daniel Peck","doi":"10.1017/S1047951124035959","DOIUrl":"10.1017/S1047951124035959","url":null,"abstract":"<p><strong>Background: </strong>Endomyocardial biopsy remains the gold standard for cardiac cellular rejection surveillance after heart transplantation. We studied a novel non-invasive index of left ventricular relaxation to detect cardiac cellular rejection in paediatric heart transplant patients.</p><p><strong>Methods: </strong>This is a single-centre retrospective study of paediatric heart transplant patients who underwent endomyocardial biopsy from June 2014 to September 2021. Left ventricular relaxation index was calculated as the sum of diastolic tissue Doppler imaging velocities (E) of the left ventricular lateral, septal, and posterior walls divided by the percentage of the left ventricular posterior wall thinning by M-mode. Statistical analysis included <i>t</i>-tests and Mann-Whitney tests to compare means and medians between treatment and non-treatment groups. We used the cut-off with the maximum Youden index to compare the sensitivity and specificity of left ventricular relaxation index to detect rejection.</p><p><strong>Results: </strong>The study included 65 patients who underwent 246 cardiac catheterizations and endomyocardial biopsies. Out of 246, 192 procedures were included and 54 were excluded due to recent transplants or lack of echocardiographic data. A total of 114 demonstrated Grade 0R, 68 Grade 1R, 8 Grade 2R, and 2 Grade 3R allograft rejection. The difference in mean left ventricular relaxation index between treatment versus non-treatment groups (2R, 3R vs. 0R, 1R) was not statistically significant (<i>p</i> = 0.917). A left ventricular relaxation index cut-off of 0.73 had the highest Youden index with good sensitivity (100%) and poor specificity (23%) for detecting rejections with grades 2R and 3R.</p><p><strong>Conclusion: </strong>Left ventricular relaxation index, a novel index of left ventricular relaxation, was not a sensitive or specific predictor of cardiac cellular rejection in paediatric heart transplants.</p>","PeriodicalId":9435,"journal":{"name":"Cardiology in the Young","volume":" ","pages":"1-5"},"PeriodicalIF":0.9,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142589424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management of a giant left coronary artery aneurysm mimicking cardiac mass. 模仿心脏肿块的巨大左冠状动脉动脉瘤的手术治疗。
IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-06 DOI: 10.1017/S1047951124026921
Hong Zhu, Haisong Bu

The giant coronary artery aneurysm is a very rare finding (0.02% of the general population), in which the right coronary artery is most often affected by aneurysms. Herein, we present a rare case of a giant left coronary artery aneurysm involving multiple major coronary arteries and compressing the cardiac cavity. The giant coronary artery aneurysm was opened and explored under cardiopulmonary bypass, and many mixed thrombi and calcified tissue were exposed. The patient was discharged uneventfully 7 days after surgery. The best management strategy at present is based on case reports, small case series, and personal experience. Treatment must be individualized according to the aetiology, location, symptoms, size, disease progression, the existence of infection, and the degree of any coexisting atherosclerosis. Surgery is a good alternative, particularly if a giant coronary artery aneurysm has a high risk of rupture and compressing the cardiac cavity. Even today, the treatment strategy is still open to debate and a clear evidence-based management strategy has not been established.

巨大冠状动脉瘤是一种非常罕见的疾病(占总人口的 0.02%),其中右冠状动脉瘤最常见。在此,我们展示了一例罕见的左冠状动脉巨大动脉瘤病例,该动脉瘤累及多支主要冠状动脉并压迫心腔。我们在心肺旁路手术中打开并探查了巨大的冠状动脉瘤,暴露出许多混合血栓和钙化组织。术后 7 天,患者顺利出院。目前的最佳治疗策略是基于病例报告、小型病例系列和个人经验。治疗必须根据病因、位置、症状、大小、疾病进展、是否存在感染以及合并动脉粥样硬化的程度进行个体化。手术是一个不错的选择,尤其是当巨大冠状动脉瘤有破裂和压迫心腔的高风险时。时至今日,治疗策略仍有待商榷,以证据为基础的明确管理策略尚未确立。
{"title":"Surgical management of a giant left coronary artery aneurysm mimicking cardiac mass.","authors":"Hong Zhu, Haisong Bu","doi":"10.1017/S1047951124026921","DOIUrl":"https://doi.org/10.1017/S1047951124026921","url":null,"abstract":"<p><p>The giant coronary artery aneurysm is a very rare finding (0.02% of the general population), in which the right coronary artery is most often affected by aneurysms. Herein, we present a rare case of a giant left coronary artery aneurysm involving multiple major coronary arteries and compressing the cardiac cavity. The giant coronary artery aneurysm was opened and explored under cardiopulmonary bypass, and many mixed thrombi and calcified tissue were exposed. The patient was discharged uneventfully 7 days after surgery. The best management strategy at present is based on case reports, small case series, and personal experience. Treatment must be individualized according to the aetiology, location, symptoms, size, disease progression, the existence of infection, and the degree of any coexisting atherosclerosis. Surgery is a good alternative, particularly if a giant coronary artery aneurysm has a high risk of rupture and compressing the cardiac cavity. Even today, the treatment strategy is still open to debate and a clear evidence-based management strategy has not been established.</p>","PeriodicalId":9435,"journal":{"name":"Cardiology in the Young","volume":" ","pages":"1-3"},"PeriodicalIF":0.9,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142581598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of clinical risk factors for coronary artery lesions in children with Kawasaki disease: a retrospective cohort study. 川崎病患儿冠状动脉病变临床风险因素的识别:一项回顾性队列研究。
IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-05 DOI: 10.1017/S1047951124000829
Xiangna Yang, Jiayi Zou, Hao Nie, Gang Zhang, Yin Liao, Jian Deng, Yanfei Wang

Background: Coronary artery lesions are the most severe complications of Kawasaki disease. Despite recent advances, evidence of the association between risk factors and coronary artery lesion is lacking. In this study, we demonstrated the potential clinical indicators that could assist to evaluate the prevalence of coronary artery lesion among paediatric patients with Kawasaki disease.

Methods: We retrospectively enrolled 260 paediatric patients with Kawasaki disease. Patients with coronary dilation, coronary aneurysm, and intimal thickening of coronary arteries were included in this study. Medical records of each patient were collected. Logistic regression analysis was performed to explore risk factors and the occurrence of coronary artery lesion in patients with Kawasaki disease.

Results: Respectively, 64 (24.6%), 39 (15%), and 56 patients (21.5%) of the participants had coronary dilation, coronary aneurysm, and intimal thickening of coronary arteries. Univariate analysis revealed that age, gender, duration of fever, time of initial use of intravenous immunoglobulin, erythrocyte sedimentation rate, white blood cell counts, time of platelet increase, the maximum value of platelet, albumin, and immunoglobulin G level was associated with coronary artery lesion. In multivariable logistic analysis, those younger and mainly males were associated with all three outcomes of coronary artery lesion, lower serum albumin levels, and later initial use of intravenous immunoglobulin were linked to a higher risk of coronary dilation and coronary aneurysm.

Conclusions: The potential risk factors that could be used to estimate the occurrence of coronary artery lesion in Kawasaki disease patients are young age, male, lower serum albumin lever, and later initial use of intravenous immunoglobulin. However, long-term follow-up and multi-centre studies are required to verify our findings in the future.

背景:冠状动脉病变是川崎病最严重的并发症。尽管最近取得了一些进展,但仍缺乏风险因素与冠状动脉病变之间关联的证据。在这项研究中,我们展示了有助于评估川崎病儿科患者冠状动脉病变患病率的潜在临床指标:我们回顾性地纳入了 260 名川崎病儿科患者。研究纳入了冠状动脉扩张、冠状动脉瘤和冠状动脉内膜增厚的患者。收集了每位患者的医疗记录。对川崎病患者冠状动脉病变发生的危险因素进行逻辑回归分析:结果:分别有 64 名(24.6%)、39 名(15%)和 56 名(21.5%)患者出现冠状动脉扩张、冠状动脉瘤和冠状动脉内膜增厚。单变量分析显示,年龄、性别、发热持续时间、首次使用静脉免疫球蛋白的时间、红细胞沉降率、白细胞计数、血小板增加时间、血小板最大值、白蛋白和免疫球蛋白 G 水平与冠状动脉病变有关。在多变量逻辑分析中,年龄较小且主要为男性的患者与冠状动脉病变的所有三种结果都有关联,血清白蛋白水平较低以及较晚开始使用静脉注射免疫球蛋白与冠状动脉扩张和冠状动脉瘤的风险较高有关:可以用来估计川崎病患者发生冠状动脉病变的潜在危险因素是年轻、男性、血清白蛋白水平较低以及较晚开始使用静脉免疫球蛋白。不过,今后还需要长期随访和多中心研究来验证我们的发现。
{"title":"Identification of clinical risk factors for coronary artery lesions in children with Kawasaki disease: a retrospective cohort study.","authors":"Xiangna Yang, Jiayi Zou, Hao Nie, Gang Zhang, Yin Liao, Jian Deng, Yanfei Wang","doi":"10.1017/S1047951124000829","DOIUrl":"https://doi.org/10.1017/S1047951124000829","url":null,"abstract":"<p><strong>Background: </strong>Coronary artery lesions are the most severe complications of Kawasaki disease. Despite recent advances, evidence of the association between risk factors and coronary artery lesion is lacking. In this study, we demonstrated the potential clinical indicators that could assist to evaluate the prevalence of coronary artery lesion among paediatric patients with Kawasaki disease.</p><p><strong>Methods: </strong>We retrospectively enrolled 260 paediatric patients with Kawasaki disease. Patients with coronary dilation, coronary aneurysm, and intimal thickening of coronary arteries were included in this study. Medical records of each patient were collected. Logistic regression analysis was performed to explore risk factors and the occurrence of coronary artery lesion in patients with Kawasaki disease.</p><p><strong>Results: </strong>Respectively, 64 (24.6%), 39 (15%), and 56 patients (21.5%) of the participants had coronary dilation, coronary aneurysm, and intimal thickening of coronary arteries. Univariate analysis revealed that age, gender, duration of fever, time of initial use of intravenous immunoglobulin, erythrocyte sedimentation rate, white blood cell counts, time of platelet increase, the maximum value of platelet, albumin, and immunoglobulin G level was associated with coronary artery lesion. In multivariable logistic analysis, those younger and mainly males were associated with all three outcomes of coronary artery lesion, lower serum albumin levels, and later initial use of intravenous immunoglobulin were linked to a higher risk of coronary dilation and coronary aneurysm.</p><p><strong>Conclusions: </strong>The potential risk factors that could be used to estimate the occurrence of coronary artery lesion in Kawasaki disease patients are young age, male, lower serum albumin lever, and later initial use of intravenous immunoglobulin. However, long-term follow-up and multi-centre studies are required to verify our findings in the future.</p>","PeriodicalId":9435,"journal":{"name":"Cardiology in the Young","volume":" ","pages":"1-9"},"PeriodicalIF":0.9,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142575058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An infant case of coronary artery aneurysms with no systemic symptoms after treatment for Kawasaki disease. 治疗川崎病后无全身症状的冠状动脉瘤婴儿病例。
IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-05 DOI: 10.1017/S1047951124025563
Yumiko Asai, Takanori Suzuki, Midori Yamada

This case is a 4-month-old patient with Kawasaki disease who showed coronary artery lesions after a disease relapse. Following the guidelines from the Randomised Controlled Trial to Assess Immunoglobulin plus Steroid Efficacy, the patient initially saw an improvement in symptoms. However, a relapse occurred despite low levels of C-reactive protein, leading to significant coronary artery growth. Treatment with a third dose of intravenous immunoglobulin and cyclosporine led to a slow reduction in the size of the coronary artery abnormalities. This case highlights the difficulty in monitoring Kawasaki disease progression through clinical symptoms and C-reactive protein levels alone. We also emphasise the necessity of echocardiographic monitoring in patients receiving anti-inflammatory treatments, including steroids, because coronary artery problems can arise or continue without the usual signs of Kawasaki disease or increased C-reactive protein levels.

本病例是一名 4 个月大的川崎病患者,在疾病复发后出现冠状动脉病变。根据 "评估免疫球蛋白加类固醇疗效的随机对照试验 "的指导方针,患者的症状最初有所改善。然而,尽管 C 反应蛋白水平很低,但病情还是复发了,导致冠状动脉明显增生。使用第三剂静脉注射免疫球蛋白和环孢素治疗后,冠状动脉畸形慢慢缩小。本病例凸显了仅通过临床症状和 C 反应蛋白水平来监测川崎病进展的困难。我们还强调了对接受类固醇等抗炎治疗的患者进行超声心动图监测的必要性,因为冠状动脉问题可能在没有川崎病通常症状或 C 反应蛋白水平升高的情况下出现或持续。
{"title":"An infant case of coronary artery aneurysms with no systemic symptoms after treatment for Kawasaki disease.","authors":"Yumiko Asai, Takanori Suzuki, Midori Yamada","doi":"10.1017/S1047951124025563","DOIUrl":"https://doi.org/10.1017/S1047951124025563","url":null,"abstract":"<p><p>This case is a 4-month-old patient with Kawasaki disease who showed coronary artery lesions after a disease relapse. Following the guidelines from the Randomised Controlled Trial to Assess Immunoglobulin plus Steroid Efficacy, the patient initially saw an improvement in symptoms. However, a relapse occurred despite low levels of C-reactive protein, leading to significant coronary artery growth. Treatment with a third dose of intravenous immunoglobulin and cyclosporine led to a slow reduction in the size of the coronary artery abnormalities. This case highlights the difficulty in monitoring Kawasaki disease progression through clinical symptoms and C-reactive protein levels alone. We also emphasise the necessity of echocardiographic monitoring in patients receiving anti-inflammatory treatments, including steroids, because coronary artery problems can arise or continue without the usual signs of Kawasaki disease or increased C-reactive protein levels.</p>","PeriodicalId":9435,"journal":{"name":"Cardiology in the Young","volume":" ","pages":"1-3"},"PeriodicalIF":0.9,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142575050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis and surgical treatment for complete atrioventricular septal defect with intact atrial septum. 伴有完整房间隔的完全性房室间隔缺损的诊断和手术治疗。
IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-31 DOI: 10.1017/S104795112402691X
Erika Yuasa, Koichi Toda, Takaya Hoashi

A six-month-old boy with Down syndrome, complete atrioventricular septal defect with intact atrial septum, and moderate left-sided atrioventricular valve regurgitation underwent surgery. The presence of a common atrioventricular junction could not be diagnosed preoperatively. Postoperative left-sided atrioventricular valve regurgitation remained mild by complete cleft closure, direct closure of incised atrial septum, and patch augmentation of the underside of septum primum.

一名六个月大的唐氏综合征男孩接受了手术,他患有完全性房室间隔缺损,心房间隔完整,左侧房室瓣中度反流。术前无法确诊是否存在房室总交界。术后通过完全闭合裂隙、直接闭合切开的房间隔以及在房间隔前端下方进行补片增强,左侧房室瓣反流仍然很轻微。
{"title":"Diagnosis and surgical treatment for complete atrioventricular septal defect with intact atrial septum.","authors":"Erika Yuasa, Koichi Toda, Takaya Hoashi","doi":"10.1017/S104795112402691X","DOIUrl":"https://doi.org/10.1017/S104795112402691X","url":null,"abstract":"<p><p>A six-month-old boy with Down syndrome, complete atrioventricular septal defect with intact atrial septum, and moderate left-sided atrioventricular valve regurgitation underwent surgery. The presence of a common atrioventricular junction could not be diagnosed preoperatively. Postoperative left-sided atrioventricular valve regurgitation remained mild by complete cleft closure, direct closure of incised atrial septum, and patch augmentation of the underside of septum primum.</p>","PeriodicalId":9435,"journal":{"name":"Cardiology in the Young","volume":" ","pages":"1-3"},"PeriodicalIF":0.9,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of exclusive human milk diet in a neonate with single ventricle physiology supported on a ventricular assist device as a bridge to heart transplantation: case report. 在使用心室辅助装置的单心室新生儿中使用纯人奶饮食作为心脏移植的桥梁:病例报告。
IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-30 DOI: 10.1017/S1047951124026775
Megan L Horsley, Sarah M Reyes, Angela Lorts

Malnutrition is common among paediatric heart failure patients, with nutritional rehabilitation critical for survival and optimal health outcomes. Ventricular assist devices have been associated with improved growth, though additional nutritional support may be needed. Here, we report the use of human milk-based fortifiers to avoid severe malnutrition in a neonate supported on a ventricular assist device until transplantation.

营养不良是儿科心力衰竭患者的常见病,营养康复对患者的生存和最佳健康状况至关重要。尽管可能需要额外的营养支持,但心室辅助装置与改善生长发育有关。在此,我们报告了使用人乳强化剂避免一名新生儿在移植前因使用心室辅助装置而出现严重营养不良的情况。
{"title":"Use of exclusive human milk diet in a neonate with single ventricle physiology supported on a ventricular assist device as a bridge to heart transplantation: case report.","authors":"Megan L Horsley, Sarah M Reyes, Angela Lorts","doi":"10.1017/S1047951124026775","DOIUrl":"https://doi.org/10.1017/S1047951124026775","url":null,"abstract":"<p><p>Malnutrition is common among paediatric heart failure patients, with nutritional rehabilitation critical for survival and optimal health outcomes. Ventricular assist devices have been associated with improved growth, though additional nutritional support may be needed. Here, we report the use of human milk-based fortifiers to avoid severe malnutrition in a neonate supported on a ventricular assist device until transplantation.</p>","PeriodicalId":9435,"journal":{"name":"Cardiology in the Young","volume":" ","pages":"1-4"},"PeriodicalIF":0.9,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late complete atrioventricular block after transcatheter perimembranous ventricular septal defect closure with the KONAR-MF™ VSD occluder: a case report and systematic review. 使用 KONAR-MF™ 室间隔缺损封堵器进行经导管膜周室间隔缺损封堵术后的晚期完全性房室传导阻滞:病例报告和系统综述。
IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-30 DOI: 10.1017/S1047951124026891
Saïd Bichali, Ali Houeijeh, François Godart

The soft nitinol KONAR-MF™ ventricular septal defect (VSD) Multifunctional Occluder (MFO) device is increasingly used for transcatheter perimembranous ventricular septal defect closure. We report for the first time a case of delayed complete atrioventricular block with pacemaker implantation 20 months post-procedure. Through a systematic review, the overall rate of persistent complete atrioventricular block was 0.6% with this device, but follow-up duration was limited.

软性镍钛诺 KONAR-MF™ 室间隔缺损(VSD)多功能封堵器(MFO)装置越来越多地被用于经导管膜周室间隔缺损封堵术。我们首次报告了一例延迟性完全性房室传导阻滞患者在术后 20 个月植入起搏器。通过系统回顾,使用该装置的持续性完全房室传导阻滞的总体发生率为 0.6%,但随访时间有限。
{"title":"Late complete atrioventricular block after transcatheter perimembranous ventricular septal defect closure with the KONAR-MF™ VSD occluder: a case report and systematic review.","authors":"Saïd Bichali, Ali Houeijeh, François Godart","doi":"10.1017/S1047951124026891","DOIUrl":"https://doi.org/10.1017/S1047951124026891","url":null,"abstract":"<p><p>The soft nitinol KONAR-MF™ ventricular septal defect (VSD) Multifunctional Occluder (MFO) device is increasingly used for transcatheter perimembranous ventricular septal defect closure. We report for the first time a case of delayed complete atrioventricular block with pacemaker implantation 20 months post-procedure. Through a systematic review, the overall rate of persistent complete atrioventricular block was 0.6% with this device, but follow-up duration was limited.</p>","PeriodicalId":9435,"journal":{"name":"Cardiology in the Young","volume":" ","pages":"1-4"},"PeriodicalIF":0.9,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of dominant ventricle morphology and additional ventricular chamber size on clinical outcomes in patients with Fontan circulation. 优势心室形态和额外心室腔大小对丰坦循环患者临床预后的影响。
IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-30 DOI: 10.1017/S1047951124026581
Massimo A Padalino, Matteo Ponzoni, Elena Reffo, Danila Azzolina, Annachiara Cavaliere, Filippo Puricelli, Giulio Cabrelle, Emma Bergonzoni, Irene Cao, Anna Gozzi, Biagio Castaldi, Vladimiro Vida, Giovanni Di Salvo

Objectives: The functional roles of ventricular dominance and additional ventricular chamber after Fontan operation are still uncertain. We aim to assess and correlate such anatomical features to late clinical outcomes.

Methods: Fontan patients undergoing cardiac MRI and cardiopulmonary exercise test between January 2020 and December 2022 were retrospectively reviewed. Clinical, cardiac MRI, and cardiopulmonary exercise test data from the last follow-up were analysed.

Results: Fifty patients were analysed: left dominance was present in 29 patients (58%, median age 20 years, interquartile range:16-26). At a median follow-up after the Fontan operation was 16 years (interquartile range: 4-42), NYHA classes III and IV was present in 3 patients (6%), 4 (8%) underwent Fontan conversion, 2 (4%) were listed for heart transplantation, and 2 (4%) died. Statistical analysis showed that the additional ventricular chamber was larger (>20 mL/m2) in patients with a right dominant ventricle (p = 0.01), and right dominance was associated with a higher incidence of post-operative low-cardiac output syndrome (p = 0.043). Left ventricular dominance was associated with a better ejection fraction (p = 0.04), less extent of late gadolinium enhancement (p = 0.022), higher metabolic equivalents (p = 0.01), and higher peak oxygen consumption (p = 0.033). A larger additional ventricular chamber was associated with a higher need for post-operative extracorporeal membrane oxygenation support (p = 0.007), but it did not influence functional parameters on cardiac MRI or cardiopulmonary exercise test.

Conclusions: In Fontan patients, left ventricular dominance correlated to better functional outcomes. Conversely, a larger additional ventricular chamber is more frequent in right ventricular dominance and can negatively affect the early post-Fontan course.

目的:Fontan手术后心室优势和附加心室腔的功能作用仍不确定。我们旨在评估这些解剖学特征与后期临床结果的相关性:回顾性分析 2020 年 1 月至 2022 年 12 月期间接受心脏核磁共振成像和心肺运动测试的丰坦患者。对最后一次随访的临床、心脏磁共振成像和心肺运动测试数据进行分析:对50名患者进行了分析:29名患者(58%,中位年龄20岁,四分位数间距:16-26)存在左侧优势。丰坦手术后的中位随访时间为16年(四分位间距:4-42),3名患者(6%)的NYHA分级为III级和IV级,4名患者(8%)进行了丰坦转换,2名患者(4%)被列入心脏移植名单,2名患者(4%)死亡。统计分析显示,右心室占优势的患者额外的心室腔更大(>20 mL/m2)(p = 0.01),右心室占优势与术后低心排综合征发生率较高有关(p = 0.043)。左心室优势与较好的射血分数(p = 0.04)、较小的晚期钆增强程度(p = 0.022)、较高的代谢当量(p = 0.01)和较高的峰值耗氧量(p = 0.033)相关。更大的额外心室腔与更高的术后体外膜氧合支持需求相关(p = 0.007),但并不影响心脏核磁共振成像或心肺运动测试的功能参数:结论:在Fontan患者中,左心室优势与更好的功能预后相关。结论:在丰坦患者中,左心室优势与较好的功能预后相关,相反,右心室优势更常见于较大的附加心室腔,会对丰坦术后的早期疗程产生负面影响。
{"title":"The impact of dominant ventricle morphology and additional ventricular chamber size on clinical outcomes in patients with Fontan circulation.","authors":"Massimo A Padalino, Matteo Ponzoni, Elena Reffo, Danila Azzolina, Annachiara Cavaliere, Filippo Puricelli, Giulio Cabrelle, Emma Bergonzoni, Irene Cao, Anna Gozzi, Biagio Castaldi, Vladimiro Vida, Giovanni Di Salvo","doi":"10.1017/S1047951124026581","DOIUrl":"https://doi.org/10.1017/S1047951124026581","url":null,"abstract":"<p><strong>Objectives: </strong>The functional roles of ventricular dominance and additional ventricular chamber after Fontan operation are still uncertain. We aim to assess and correlate such anatomical features to late clinical outcomes.</p><p><strong>Methods: </strong>Fontan patients undergoing cardiac MRI and cardiopulmonary exercise test between January 2020 and December 2022 were retrospectively reviewed. Clinical, cardiac MRI, and cardiopulmonary exercise test data from the last follow-up were analysed.</p><p><strong>Results: </strong>Fifty patients were analysed: left dominance was present in 29 patients (58%, median age 20 years, interquartile range:16-26). At a median follow-up after the Fontan operation was 16 years (interquartile range: 4-42), NYHA classes III and IV was present in 3 patients (6%), 4 (8%) underwent Fontan conversion, 2 (4%) were listed for heart transplantation, and 2 (4%) died. Statistical analysis showed that the additional ventricular chamber was larger (>20 mL/m<sup>2</sup>) in patients with a right dominant ventricle (<i>p</i> = 0.01), and right dominance was associated with a higher incidence of post-operative low-cardiac output syndrome (<i>p</i> = 0.043). Left ventricular dominance was associated with a better ejection fraction (<i>p</i> = 0.04), less extent of late gadolinium enhancement (<i>p</i> = 0.022), higher metabolic equivalents (<i>p</i> = 0.01), and higher peak oxygen consumption (<i>p</i> = 0.033). A larger additional ventricular chamber was associated with a higher need for post-operative extracorporeal membrane oxygenation support (<i>p</i> = 0.007), but it did not influence functional parameters on cardiac MRI or cardiopulmonary exercise test.</p><p><strong>Conclusions: </strong>In Fontan patients, left ventricular dominance correlated to better functional outcomes. Conversely, a larger additional ventricular chamber is more frequent in right ventricular dominance and can negatively affect the early post-Fontan course.</p>","PeriodicalId":9435,"journal":{"name":"Cardiology in the Young","volume":" ","pages":"1-10"},"PeriodicalIF":0.9,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics and outcomes of patients with stent implantation for coronary artery lesions caused by Kawasaki disease - insights from second-generation stent implantation. 川崎病引起的冠状动脉病变的支架植入患者的特征和预后--第二代支架植入的启示。
IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-30 DOI: 10.1017/S1047951124026593
Natsuko Ishi, Etsuko Tsuda

Background: Adult Kawasaki patients may require intervention for occlusive coronary artery disease. Some adverse effects of first-generation drug-eluting stent implantation with sirolimus have been reported in this population.

Methods: A total of nine lesions in eight (seven males, one female) patients who underwent stent implantations in this population between 2000 and 2021 were reviewed.

Results: The age at stent implantation ranged from 31 to 47 years, with a median of 37 years. There were six lesions treated by primary percutaneous transluminal coronary interventions, and three by elective procedures. A coronary aneurysm was found in two lesions, and coronary artery calcification was found in all culprit lesions. The numbers of everolimus-eluting stents, sirolimus-eluting stents and bare metal stents were six, two, and one, respectively. As anti- thrombotic therapy, aspirin, clopidogrel, and prasugrel were given to four, three, and one, respectively. Warfarin was given to five patients. The follow-up ranged from 2 to 12 years, with a median of 4 years. Follow-up angiograms were performed for eight lesions, at 2 to 38 months, with a median of 11 months. The patency of the target vessel was confirmed in all eight vessels. Slight malapposition, and peri-stent contrast staining were found in two lesions each.

Conclusion: Acute coronary syndrome due to coronary artery lesions caused by Kawasaki disease occurred, even in lesions without any apparent coronary artery aneurysms. In our study, we show safe and efficacious placement of second-generation stent without adverse effects during the short-term follow-up, but long-term follow-up is needed to determine the efficacy and complication.

背景:成年川崎患者可能需要介入治疗闭塞性冠状动脉疾病。据报道,在该人群中使用西罗莫司植入第一代药物洗脱支架会产生一些不良反应:方法:对 2000 年至 2021 年期间在这一人群中接受支架植入术的 8 名患者(7 名男性,1 名女性)的 9 例病变进行了回顾性研究:植入支架时的年龄从 31 岁到 47 岁不等,中位数为 37 岁。有六例病变接受了原发性经皮冠状动脉腔内介入治疗,三例接受了选择性手术。在两个病变中发现了冠状动脉瘤,在所有罪魁祸首病变中都发现了冠状动脉钙化。使用依维莫司洗脱支架、西罗莫司洗脱支架和裸金属支架的病例分别为 6 例、2 例和 1 例。在抗血栓治疗方面,阿司匹林、氯吡格雷和普拉格雷的使用人数分别为 4 人、3 人和 1 人。5名患者接受了华法林治疗。随访时间从 2 年到 12 年不等,中位数为 4 年。对 8 例病变进行了随访血管造影,随访时间从 2 个月到 38 个月不等,中位数为 11 个月。所有八条血管都证实靶血管通畅。结论:冠状动脉病变导致的急性冠状动脉综合征是由冠状动脉病变引起的:结论:川崎病引起的冠状动脉病变导致的急性冠状动脉综合征时有发生,即使病变部位没有明显的冠状动脉瘤。在我们的研究中,我们发现第二代支架的置入安全有效,短期随访无不良反应,但需要长期随访以确定疗效和并发症。
{"title":"Characteristics and outcomes of patients with stent implantation for coronary artery lesions caused by Kawasaki disease - insights from second-generation stent implantation.","authors":"Natsuko Ishi, Etsuko Tsuda","doi":"10.1017/S1047951124026593","DOIUrl":"https://doi.org/10.1017/S1047951124026593","url":null,"abstract":"<p><strong>Background: </strong>Adult Kawasaki patients may require intervention for occlusive coronary artery disease. Some adverse effects of first-generation drug-eluting stent implantation with sirolimus have been reported in this population.</p><p><strong>Methods: </strong>A total of nine lesions in eight (seven males, one female) patients who underwent stent implantations in this population between 2000 and 2021 were reviewed.</p><p><strong>Results: </strong>The age at stent implantation ranged from 31 to 47 years, with a median of 37 years. There were six lesions treated by primary percutaneous transluminal coronary interventions, and three by elective procedures. A coronary aneurysm was found in two lesions, and coronary artery calcification was found in all culprit lesions. The numbers of everolimus-eluting stents, sirolimus-eluting stents and bare metal stents were six, two, and one, respectively. As anti- thrombotic therapy, aspirin, clopidogrel, and prasugrel were given to four, three, and one, respectively. Warfarin was given to five patients. The follow-up ranged from 2 to 12 years, with a median of 4 years. Follow-up angiograms were performed for eight lesions, at 2 to 38 months, with a median of 11 months. The patency of the target vessel was confirmed in all eight vessels. Slight malapposition, and peri-stent contrast staining were found in two lesions each.</p><p><strong>Conclusion: </strong>Acute coronary syndrome due to coronary artery lesions caused by Kawasaki disease occurred, even in lesions without any apparent coronary artery aneurysms. In our study, we show safe and efficacious placement of second-generation stent without adverse effects during the short-term follow-up, but long-term follow-up is needed to determine the efficacy and complication.</p>","PeriodicalId":9435,"journal":{"name":"Cardiology in the Young","volume":" ","pages":"1-7"},"PeriodicalIF":0.9,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ebstein's anomaly with coarctation of the aorta and a bicuspid aortic valve: a case report of a rare association with unique prenatal findings. 埃布斯坦氏畸形伴主动脉共动脉瘤和双尖主动脉瓣:一例罕见病例报告,具有独特的产前发现。
IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-30 DOI: 10.1017/S1047951124026404
Yuki Kawasaki, Yosuke Murakami, Eiji Ehara

Ebstein's anomaly is rarely accompanied by coarctation of the aorta, although patients with Ebstein's anomaly have a relatively small left ventricle. Here, we report a rare case of Ebstein's anomaly with coarctation of the aorta and a bicuspid aortic valve. We compared the foetal echocardiographic parameters of five previous cases with Ebstein's anomaly without left heart obstruction to explore the association between left ventricular volume, Ebstein's anomaly severity, and left heart obstruction.

尽管埃布斯坦氏异常患者的左心室相对较小,但他们很少伴有主动脉共动脉症。在此,我们报告了一例罕见的埃布斯坦氏畸形伴有主动脉共动脉症和主动脉瓣双瓣的病例。我们比较了之前五例无左心梗的埃布斯坦畸形胎儿超声心动图参数,以探讨左心室容积、埃布斯坦畸形严重程度和左心梗之间的关联。
{"title":"Ebstein's anomaly with coarctation of the aorta and a bicuspid aortic valve: a case report of a rare association with unique prenatal findings.","authors":"Yuki Kawasaki, Yosuke Murakami, Eiji Ehara","doi":"10.1017/S1047951124026404","DOIUrl":"https://doi.org/10.1017/S1047951124026404","url":null,"abstract":"<p><p>Ebstein's anomaly is rarely accompanied by coarctation of the aorta, although patients with Ebstein's anomaly have a relatively small left ventricle. Here, we report a rare case of Ebstein's anomaly with coarctation of the aorta and a bicuspid aortic valve. We compared the foetal echocardiographic parameters of five previous cases with Ebstein's anomaly without left heart obstruction to explore the association between left ventricular volume, Ebstein's anomaly severity, and left heart obstruction.</p>","PeriodicalId":9435,"journal":{"name":"Cardiology in the Young","volume":" ","pages":"1-3"},"PeriodicalIF":0.9,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiology in the Young
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1